Product information

Current status:

Marketed

Current status date:

2016-09-15

Original market date: ^{See footnote 1}

2016-09-15

Product name:

NXSTAGE PUREFLOW SOLUTION RFP-209-CAN

DIN:

02443295 Electronic product monograph is not available

Company:

NXSTAGE MEDICAL INC
350 Merrimack Street
Lawrence
Massachusetts
United States 01843

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Haemodialysis

Number of active ingredient(s):

6

Schedule(s):

Ethical

American Hospital Formulary Service (AHFS): ^{See footnote 3}

40:34.00* ^{See footnote6} 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

B05ZA HEMODIALYTICS, CONCENTRATES

Active ingredient group (AIG) number:^{See footnote5}

0633087010